This study is evaluating an investigational medicine that may help reduce symptoms of Post Traumatic Stress Disorder (PTSD) in adults.
This study is only being conducted at our Brisbane, Canberra and Melbourne sites.
Apply Now
This 3-month study is exploring whether a psilocybin-assisted therapy can help reduce emotional distress and improve well-being in people living with cancer.
This study is only being conducted at our Melbourne site.
Apply Now
This 5-month clinical trial is exploring whether an investigational medicine can help reduce symptoms in people aged 18 to 65 who are living with treatment-resistant depression (TRD).
This study is only being conducted at our Melbourne site.
Apply Now
This study is exploring whether a weekly injection of an investigational medicine, taken with regular antidepressant medication, can help delay the return of major depressive disorder (MDD) symptoms. It is for adults aged 18 to 75 who are currently in remission or near remission but still experience some ongoing symptoms.
This study is only being conducted at our Melbourne site.
Apply Now
This 5-month clinical trial is exploring whether an investigational medicine can help reduce symptoms in people aged 18 to 65 who are living with treatment-resistant depression (TRD).
This study is only being conducted at our Melbourne site.
Apply Now
This clinical research study is evaluating an investigational oral medicine for adults living with generalised anxiety disorder who also experience insomnia or poor sleep.
This study is being conducted at our Melbourne site.
Apply Now
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
